Possible involvement of neuropeptide y Y1 receptors in antidepressant like effect of agmatine in rats

Peptides

Volumn 47, Issue , 2013, Pages 7-11

  Kotagale, Nandkishor R ^a   Paliwal, Nikhilesh P ^a   Aglawe, Manish M ^a   Umekar, Milind J ^a   Taksande, Brijesh G ^a  

^a New Kamptee   (India)

Author keywords

Agmatine; Depression; FST; Immobility time; Neuropeptide Y; NPYY1 receptors

Indexed keywords

AGMATINE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG POTENTIATION; FORCED SWIMMING TEST; IMMOBILITY; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS;

AGMATINE; DEPRESSION; FST; IMMOBILITY TIME; NEUROPEPTIDE Y; NPY Y1 RECEPTORS;

AGMATINE; ANIMALS; ANTIDEPRESSIVE AGENTS; ARGININE; BEHAVIOR, ANIMAL; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; NEUROPEPTIDE Y; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; SWIMMING;

EID: 84885138384     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.04.018     Document Type: Article

References (44)

1. Auguet M, Viossat I, Marin JG, Chabrier PE. Selective inhibition of inducible nitric oxide synthase by agmatine.JpnJ Pharmacol 1995;69:285-7.
2. Bernstein HG, Stich C, Jäger K, Dobrowolny H, Wick M, Steiner J, et al. Agmati-nase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders. Neuropharmacology 2012;62:237-46.
3. Caberlotto L, Fuxe K, Overstreet DH, Gerrard P, Hurd YL. Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment. Mol Biol Rep 1998;59:58-65. (Pubitemid 28408447)
4. Caberlotto L, Jimenez P, Overstreet DH, Hurd YL, Mathe AA, Fuxe K. Alterations in neuropeptide Y levels and Y1 binding sites in the flinders sensitive rats, a genetic animal model of depression. Neurosci Lett 1999;265:191-4. (Pubitemid 29207398)
5. Christiansen SH, Olesen MV, Wörtwein G, Woldbye DP. Fluoxetine revert chronic restraint stress-induced depression-like behaviour and increases neuropeptide Y and galanin expression in mice. Behav Brain Res 2011;216(2):585-91.
6. Crespi F. Influence of neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: an in vivo electrochemical study. Brain Res 2011;1407:27-37.
7. Deo GS, Dandekar MP, Upadhya MA, Kokare DM, Subhedar NK. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: behavioral and immunocytochemical evidences. Brain Res 2010;1318:77-86.
8. Doods HN, Wieland HA, Engel W, Eberlein W, Willim KD, Entzeroth M, et al. BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties. Regul Pept 1996;65:71-7. (Pubitemid 26273589)
9. Gehlert DR, Thompson LK, Hemrick-Luecke SK, Shaw J. Monoaminergic compensation in the neuropeptide Y deficient mouse brain. Neuropeptides 2008;42(3):367-75.
10. Goyal SN, Upadhya MA, Kokare DM, Bhisikar SM, Subhedar NK. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbec-tomized rats: involvement of NPY Y1 receptors. Brain Res 2009;1266:45-53.
11. Goyal SN, Kokare DM, Chopde CT, Subhedar NK. Alpha-melanocyte stimulating hormone antagonizes antidepressant-like effect of neuropeptide Y in Porsolt's test in rats. Pharmacol Biochem Behav 2006;85:369-77. (Pubitemid 44889261)
12. Halaris A, Plietz J. Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs 2007;21:885-900. (Pubitemid 47557104)
13. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 2004;38(4):213-24. (Pubitemid 39158860)
14. Heilig M. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharma-cology 1993;8:357-63. (Pubitemid 23162961)
15. Heilig M, Thorsell A. Brain neuropeptide Y(NPY) in stress and alcohol dependence. Rev Neurosci 2002;13:85-94.
16. Husum H, Mathé AA. Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes. Neuropsychopharmacology 2002;27(5): 756-64. (Pubitemid 35335892)
17. Jiang XZ, Li YF, Zhang YZ, Chen HX, Li J, Wang NP. 5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine. Yao Xue Xue Bao 2008;43(5):467-73.
18. Jiménez-Vasquez PA, Diaz-Cabiale Z, Caberlotto L, Bellido I, Overstreet D, Fuxe K, et al. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. EurNeu-ropsychopharmacol 2007;17(4):298-308. (Pubitemid 46135933)
19. Jiménez-Vasquez PA, Overstreet DH, Mathé AA. Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli. J Psychiatr Res 2000;34(6):405-12. (Pubitemid 32101557)
20. Kokare DM, Dandekar MP, Singru PS, Gupta GL, Subhedar NK. Involvement of alpha-MSH in the social isolation induced anxiety- and depression-like behaviors in rat. Neuropharmacology 2010;58(7):1009-18.
21. Kotagale NR, Taksande BG, Wadhwani PJ, Palhade MW, Mendhi SM, Gawande DY, et al. Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodents.source. Pharmacol Biochem Behav 2012;100:398-403.
22. Nikisch G, Agren H, Eap CB, Czernik A, Baumann P, Mathé AA. Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram. Int J Neuropsychopharmacol 2005;8(3):403-10. (Pubitemid 41002494)
23. Overstreet DH, Friedman E, Mathé AA, Yadid G. The flinders sensitive line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 2005;29(4-5):739-59. (Pubitemid 40762598)
24. Pålsson E, Fejgin K, Wass C, Klamer D. Agmatine attenuates the disruptive effects of phencyclidine on prepulse inhibition. Eur J Pharmacol 2008;590:212-6.
25. Piletz J, Baker R, Halaris A. Platelet imidazoline receptors as state marker of depressive symptomatology. J Psychiatr Res 2008;42:41-9. (Pubitemid 47562437)
26. Piletz JE, Zhu H, Ordway G, Stockmeier C, Dilly G, Reis D, et al. Imidazoline receptor proteins are decreased in the hippocampus of individuals with major depression. Biol Psychiatry 2000;48:910-9.
27. Piletz JE, Halaris AE, Chikkala D, Qu YS. Platelet I-1 imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients. J Psychiatr Res 1996;30:169-84. (Pubitemid 26335870)
28. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. London: Academic Press; 1998.
29. Porsolt RD, Anton G, Blavet N,JalfreM. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978;47:379-91.
30. Redrobe JP, Dumont Y, Fournier A, Baker GB, Quirion R. Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test. Peptides 2005;26:1394-400. (Pubitemid 41021473)
31. Redrobe JP, Dumont Y, Fournier A, Quirion R. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 2002;26(5):615-24. (Pubitemid 34260980)
32. Redrobe JP, Dumont Y, Quirion R. Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Life Sci 2002;71:2921-37. (Pubitemid 35221402)
33. Rudolf K, Eberlein W, Engel W, Wieland HA, Willim KD, Entzeroth M, et al. The first highly potent selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur J Pharmacol 1994;271:R11-3.
34. Song C, Earley B, Leonard BE. The effects of central administration of neuropeptide Yon behavior, neurotransmitter, and immune functions inthe olfactory bulbectomized rat model of depression. Brain Behav Immun 1996;10:1-16. (Pubitemid 26168466)
35. Stogner KA, Holmes PV. Neuropeptide Y exerts antidepressant-like effects in the forced swim test in rats. Eur J Pharmacol 2000;387:R9-10.
36. Sajdyk TJ, Schober DA, Gehlert DR. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Neuropharmacology 2002;43(7):1165-72. (Pubitemid 36009370)
37. Taksande BG, Kotagale NR, Nakhate KT, Mali PD, Kokare DM, Hirani K, et al. Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y. BrJ Pharmacol 2011;164:704-18.
38. Taksande BG, Kotagale NR, Patel MR, Shelkar GP, Ugale RR, Chopde CT. Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats. Eur J Pharmacol 2010;637:89-101.
39. Taksande BG, Kotagale NR, Tripathi SJ, Ugale RR, Chopde CT. Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine. Neuropharmacology 2009;57:415-24.
40. Uzbay TI. The pharmacological importance of agmatine in the brain. Neurosci Biobehav Rev 2012;36(1):502-19.
41. Widdowson PS, Ordway GA, Halaris AE. Reduced neuropeptide Y concentrations in suicide brain. J Neurochem 1992;59:73-80.
42. Wu G, Feder A, Wegener G, Bailey C, Saxena S, Charney D, et al. Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin Ther Targets 2011;15(11):1317-31.
43. Zomkowski ADE, Oscar RA, Lin J, Santos ARS, Calixto JB, Rodrigues ALS. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect inthe mouse forced swimming test. Brain Res 2004;1023(2):253-63. (Pubitemid 39221428)
44. Zomkowski ADE, Hammes L, Lin J, Calixto JB, Santos ARS, Rodrigues ALS. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 2002;13:387-91. (Pubitemid 34293175)